Mkts

Kiora Pharmaceuticals, Inc.

NASDAQ: KPRX
$1.23-0.10 (-7.52%)
As of Nov 13, 4:00 PM ET

Key statistics

Day range
1.201.39
52-week range
1.332.91
Today
Open1.36
Previous close1.23
Volume—
Valuation
Market cap5.40M
P/E ratio—
EPS (TTM)-2.47
Income & risk
Dividend / yield—
Beta-0.15
Avg volume27.5K
Discussion

KPRX News

Stories mentioning KPRX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue0.000.000.000.000.000.0020.00
Cost of Goods Sold
Gross Profit0.00
Operating Expenses
Research & Development2,1242,9282,7302,5902,5321,9242,1852,049
Sales General & Admin
Total Operating Expenses2,5107,311794.002,3962,3302,5653,6022,565
Operating Income (Loss)(2,510)(7,311)(794.00)(2,396)(2,330)(2,565)(3,602)(2,545)
Interest Income225.00277.00342.00
Interest Expense
Other Expense(47.00)(26.00)(24.00)(94.00)(16.00)97.00(60.00)(19.00)
Pretax Income(2,418)(7,166)(616.00)(2,265)(2,070)(2,158)(3,413)(2,222)
Tax Provision0.00(650.00)(643.00)(112.00)123.002,0650.000.00
Net Income (Loss)(2,418)(6,517)27.00(2,152)(2,193)(4,223)(3,413)(2,222)
Earnings Per Share (Basic)(0.58)(1.56)0.01(0.54)(0.52)(1.09)(0.81)(0.53)
Earnings Per Share (Diluted)(0.58)(1.59)0.01(0.54)(0.52)(1.02)(0.81)(0.53)
Weighted Average Shares Outstanding (Basic)4,1754,1674,2903,9894,2173,8734,2154,171
Weighted Average Shares Outstanding (Diluted)4,1754,1044,3623,9894,2174,1254,2154,171

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About KPRX

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) is a stock listed on the Nasdaq Stock Market under the ticker symbol KPRX. It last traded at $1.23 (Nov 13, 2026, 4:00 PM ET), down 7.5% on the day. That gives Kiora Pharmaceuticals a market capitalisation of $5.4M.

Over the past 52 weeks KPRX has traded between $1.33 and $2.91.

For the quarter ended Mar 31, 2026 it reported a net loss of $2.4M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026—-$2.4M
Dec 31, 2025$0-$6.5M
Sep 30, 2025$0$27.0K
Jun 30, 2025$0-$2.2M

From Kiora Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…